On Jan. 29, 2020, HTC Extraction Systems (TSXV: HTC) (OTCQB: HTPRF) announced that it had closed its previously announced purchase of all the issued and outstanding shares of Kase Farma Inc. from Starling Brands, Inc.
As part of the transaction, Kase Farma has entered into an intellectual property licensing agreement with Starling Brands that allows for a technology transfer, whereby intellectual property and technology licensed under the agreement will be utilized and deployed in HTC's Canadian facility.
Kase Farma, now a wholly owned subsidiary of HTC, is authorized to operate in the areas of hemp cultivation, extraction, refining and formulation in the State of California.
Gowling WLG was Canadian counsel to Starling Brands with respect to this transaction with a team that included Peter Simeon and Warren Cass.
Read the original article on GowlingWLG.com
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.